AI Annotation
Digital tagging and visual instruction for enhanced OR team communication
Software · EmbeddedCompany source
Company profile
About TransEnterix
Asensus Surgical, now part of KARL STORZ, is revolutionizing minimally invasive surgery through its innovative combination of robotic systems and augmented intelligence technology. The company's flagship Senhance® Surgical System features an open ergonomic design with haptic feedback and eye-tracking camera control, paired with reusable 3mm and 5mm instruments. What distinguishes Asensus is its Intelligent Surgical Unit™ (ISU™), the first intraoperative augmented intelligence system approved globally, which provides surgeons with real-time data-driven insights during procedures. The ISU™ includes AI Sight for eye-tracking camera control, AI Precision for intraoperative 3D measurement, and AI Annotation for enhanced surgical team communication. The augmentOR™ Portal extends this capability beyond the OR, offering cloud-based analytics, video review, performance evaluation, and trend analysis to support continuous learning and surgical optimization. Asensus serves surgeons, hospital administrators, and healthcare systems worldwide across multiple surgical specialties including general surgery, gynecology, urology, and pediatrics. The company's mission centers on making advanced surgical technology more accessible by removing traditional barriers while enhancing decision-making capabilities. With a focus on 'Performance-Guided Surgery™,' Asensus aims to reduce surgical variability, improve outcomes, and make the safest surgeries available everywhere through groundbreaking digital and robotic technologies.
Company description TransEnterix official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at TransEnterix?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- General surgery
- Gynecology
- Hernia repair
- Oncology
- Pediatric surgery
- Prostatectomy
- Urology
Who it serves
- Health Systems
- Hospital Administrators
- Hospitals
- Surgeons
Deployment & integration
Cloud Saas · Embedded · On Premise deployment with recorded integration context.
Geographic context
MarketsGlobal · International markets mentioned
Company sourceOfficial website
Company milestones
Platform expansion
Acquired by KARL STORZ (timing not specified). Multiple 2025 awards including Best in Biz Tech for Good, Merit Awards Health Tech Innovation, eHealthcare Leadership Award, MarCom Awards, Globee Business Awards Most Innovative Healthcare Company, NC Tech Awards Finalist, Digital Health Award, Surgical Robotics Industry Awards Finalist, TITAN Health Awards.
Partnerships
Recorded partners
- KARL STORZ (parent company/acquirer)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
AI Precision
Intraoperative 3D measurement tools for enhanced procedural reproducibility
Software · EmbeddedCompany source
AI Sight
Eye-tracking and instrument-guided camera control for autonomous surgical visualization
Software · EmbeddedCompany source
augmentOR™ Portal
Cloud-based surgical analytics platform for performance insights and continuous learning
Platform · Cloud SaaSCompany source
Intelligent Surgical Unit™ (ISU™)
First intra-operative Augmented Intelligence system providing real-time surgical insights
Software · EmbeddedCompany source
Senhance® Connect
Connectivity solution for the Senhance Surgical System
Software · EmbeddedCompany source
Senhance® Simulation
Training and simulation platform for Senhance robotic surgery
Software · On PremiseCompany source
Senhance® Surgical System
Advanced robotic-assisted surgical system with haptic feedback and open ergonomic design
Device · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
TransEnterix Senhance Surgical SystemK180163 · 510k · May 25, 2018
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Enhanced surgeon decision-making
Real-time insights during surgery
Improved surgical efficiency and quality
Through augmented intelligence features
Reduced surgical variability
Performance-guided surgery approach
Enhanced OR team communication
Digital annotation and tagging features
Multiple centers (3,239 patients across various surgical disciplines)
Safety evaluation of Senhance™ robotic system across various surgical disciplines
Demonstrated safety across 3,239 patients in multiple surgical disciplines
Global survey respondents (surgeons)
Evaluation of intraoperative digital solutions and clinical analytical dashboards for surgical decision-making and workflow efficiency
100% of surgeons felt intraoperative digital solutions will support surgeon decision-making; 97% believe solutions will impact daily practice in workflow efficiencies and/or improved patient outcomes
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Dustin Vaughan
Vice President, R&D, Robotics
06 · Company updates
Updates from TransEnterix
Recent articles published on TransEnterix's official website.
2025 MarCom Awards Winner
Read on TransEnterix2025 Globee Business Awards: Most Innovative Healthcare Company of the Year - Best of Category
Read on TransEnterixSurgical Robotics Industry Awards 2025: Finalist - Groundbreaking Technology
Read on TransEnterixNC Tech Awards 2025 Finalist
Read on TransEnterix2025 Merit Awards: Health Tech Innovation of the Year
Read on TransEnterix07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.